Sabal Trust’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-3,175
Closed -$523K 135
2019
Q1
$523K Sell
3,175
-144,066
-98% -$25.5M 0.05% 92
2018
Q4
$27.7M Sell
147,241
-5,747
-4% -$1.06M 2.84% 8
2018
Q3
$26M Buy
152,988
+28,135
+23% +$4.74M 2.3% 25
2018
Q2
$20.5M Buy
124,853
+2,753
+2% +$450K 1.95% 31
2018
Q1
$19.7M Buy
122,100
+2,698
+2% +$429K 1.89% 34
2017
Q4
$17.4M Buy
119,402
+5,208
+5% +$742K 1.78% 32
2017
Q3
$15.5M Buy
+114,194
New +$14.4M 1.55% 34

Other funds holding CME

Sabal Trust's CME Position: Q2 2019 in Review

Sabal Trust sold out of CME Group (CME) in Q2 2019, closing a stake of 3,175 shares — an estimated $523K sold.

Sabal Trust first reported a position in CME in Q3 2017 and held it in 7 quarters. The position peaked at $27.7M in Q4 2018. 978 funds tracked by Wall St. Rank hold CME as of Q2 2019.

  • Sabal Trust reported no remaining CME Group position as of Q2 2019 after selling out during the quarter.
  • Sabal Trust sold 3,175 CME Group shares in Q2 2019, an estimated $523K.
  • Sabal Trust first reported a position in CME Group in Q3 2017 and held it in 7 quarters.
  • Sabal Trust's CME Group position peaked at $27.7M in Q4 2018.
  • 978 funds tracked by Wall St. Rank held CME Group as of Q2 2019.

Based on Sabal Trust's 13F filing for Q2 2019, filed 17 Jul 2019.